PATENT CLAIM ANALYSIS

Application Number: 15755374
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["424", "422000"]

Abstract:
The invention discloses naltrexone implantable tablets which are devoid of metal salts and corticosteroids, and which provide consistent and controlled amount of naltrexone for 3 months or more; also disclosed is methods of treatment comprising the implants and methods of sterilization of the implants.

Claim (Index 7):
The Naltrexone implantable tablet composition according to  claim 1 , wherein, the strength of the Naltrexone is about 765 mg or about 903 mg.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 93.0
- Lexical Diversity: 1.34286
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10363107', '12336267', '15245338', '15715425', '14490493']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7047484333570088
- 35 USC 102 Novelty (BERT): 0.4850423718443845
- Combined Prediction Score: 0.6827778272057463
- Mean Citation Score: 168.794826
- Max Citation Score: 178.20898
- Similarity Product: 124.4254013717866

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test